FDA Approved: TNKASE — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TNKASE (tenecteplase) from Genentech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• TNKASE (tenecteplase)

Snippet

SUPPL AP for TNKASE (TENECTEPLASE)